Epilepsy-associated genes

Seizure

Volumn 44, Issue , 2017, Pages 11-20

  Wang, Jie ^a,b   Lin, Zhi Jian ^a,b   Liu, Liu ^a,b   Xu, Hai Qing ^a,b,c   Shi, Yi Wu ^a,b   Yi, Yong Hong ^a,b   He, Na ^a,b   Liao, Wei Ping ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Epilepsy; Epilepsy gene; Epilepsy related gene; Gene function; Genetics; Phenotypes

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; ALANINE TRANSFER RNA LIGASE; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; CYCLIN DEPENDENT KINASE 5; EXCITATORY AMINO ACID TRANSPORTER 2; FIBROBLAST GROWTH FACTOR; GABA TRANSPORTER 1; GLUCOSE TRANSPORTER 1; INTERFERON REGULATORY FACTOR 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KV1.2; POTASSIUM CHLORIDE COTRANSPORTER 2; PROTEIN PATCHED 1; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.6; SODIUM CHANNEL NAV1.7; SYNTAXIN 1; TRANSCRIPTION FACTOR EMX2; TUBERIN;

BRAIN DEVELOPMENT; CHILDHOOD ABSENCE EPILEPSY; EPILEPSY; EPILEPTOGENESIS; FEBRILE CONVULSION; FOCAL EPILEPSY; GENE; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; HUMAN; INHERITANCE; LENNOX GASTAUT SYNDROME; MOLECULAR PATHOLOGY; MYOCLONUS EPILEPSY; NERVE CELL DIFFERENTIATION; NEURONAL CEROID LIPOFUSCINOSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TEMPORAL LOBE EPILEPSY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; NUCLEIC ACID DATABASE;

DATABASES, NUCLEIC ACID; EPILEPSY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 85008354935     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2016.11.030     Document Type: Review

References (33)

1. [1] Pal, D.K., Pong, A.W., Chung, W.K., Genetic evaluation and counseling for epilepsy. Nat Rev Neurol 6 (2010), 445–453.
2. [2] Meng, H., Xu, H.Q., Yu, L., Lin, G.W., He, N., Su, T., et al. The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype. Hum Mutat 36 (2015), 573–580.
3. [3] Nellist, M., van den Heuvel, D., Schluep, D., Exalto, C., Goedbloed, M., Maat-Kievit, A., et al. Missense mutations to the TSC1 gene cause tuberous sclerosis complex. Eur J Hum Genet 17 (2009), 319–328.
4. [4] Jansen, A.C., Sancak, O., D'Agostino, M.D., Badhwar, A., Roberts, P., Gobbi, G., et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol 60 (2006), 528–539.
5. [5] Gronskov, K., Brondum-Nielsen, K., Dedic, A., Hjalgrim, H., A nonsense mutation in FMR1 causing fragile X syndrome. Eur J Hum Genet 19 (2011), 489–491.
6. [6] Foncke, E.M., Klein, C., Koelman, J.H., Kramer, P.L., Schilling, K., Muller, B., et al. Hereditary myoclonus-dystonia associated with epilepsy. Neurology 60 (2003), 1988–1990.
7. [7] Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen, A.S., Berkovic, S.F., Cossette, P., Delanty, N., et al. De novo mutations in epileptic encephalopathies. Nature 501 (2013), 217–221.
8. [8] Liu, X.R., Wu, M., He, N., Meng, H., Wen, L., Wang, J.L., et al. Novel PRRT2 mutations in paroxysmal dyskinesia patients with variant inheritance and phenotypes. Genes Brain Behav 12 (2013), 234–240.
9. [9] Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11 (1995), 201–203.
10. [10] De Fusco, M., Becchetti, A., Patrignani, A., Annesi, G., Gambardella, A., Quattrone, A., et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26 (2000), 275–276.
11. [11] Aridon, P., Marini, C., Di Resta, C., Brilli, E., De Fusco, M., Politi, F., et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79 (2006), 342–350.
12. [12] Heron, S.E., Smith, K.R., Bahlo, M., Nobili, L., Kahana, E., Licchetta, L., et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 44 (2012), 1188–1190.
13. [13] Suls, A., Jaehn, J.A., Kecskes, A., Weber, Y., Weckhuysen, S., Craiu, D.C., et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet 93 (2013), 967–975.
14. [14] EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium, De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet 95 (2014), 360–370.
15. [15] Ohba, C., Kato, M., Takahashi, N., Osaka, H., Shiihara, T., Tohyama, J., et al. De novo KCNT1 mutations in early-onset epileptic encephalopathy. Epilepsia 56 (2015), e121–128.
16. [16] Kodera, H., Ohba, C., Kato, M., Maeda, T., Araki, K., Tajima, D., et al. De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia 57 (2016), 566–573.
17. [17] Salzmann, A., Guipponi, M., Lyons, P.J., Fricker, L.D., Sapio, M., Lambercy, C., et al. Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy. Hum Mutat 33 (2012), 124–135.
18. [18] Escayg, A., MacDonald, B.T., Meisler, M.H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24 (2000), 343–345.
19. [19] Wallace, R.H., Scheffer, I.E., Barnett, S., Richards, M., Dibbens, L., Desai, R.R., et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 68 (2001), 859–865.
20. [20] Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., De Jonghe, P., De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68 (2001), 1327–1332.
21. [21] Ohmori, I., Ouchida, M., Ohtsuka, Y., Oka, E., Shimizu, K., Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun 295 (2002), 17–23.
22. [22] Poirier, K., Saillour, Y., Bahi-Buisson, N., Jaglin, X.H., Fallet-Bianco, C., Nabbout, R., et al. Mutations in the neuronal ss-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects. Hum Mol Genet 19 (2010), 4462–4473.
23. [23] Yu, T.W., Mochida, G.H., Tischfield, D.J., Sgaier, S.K., Flores-Sarnat, L., Sergi, C.M., et al. Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture. Nat Genet 42 (2010), 1015–1020.
24. [24] Barcia, G., Fleming, M.R., Deligniere, A., Gazula, V.R., Brown, M.R., Langouet, M., et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 44 (2012), 1255–1259.
25. [25] Vanoye, C.G., Gurnett, C.A., Holland, K.D., George, A.L. Jr., Kearney, J.A., Novel SCN3A variants associated with focal epilepsy in children. Neurobiol Dis 62 (2014), 313–322.
26. [26] Chen, Y.J., Shi, Y.W., Xu, H.Q., Chen, M.L., Gao, M.M., Sun, W.W., et al. Electrophysiological differences between the same pore region mutation in SCN1A and SCN3A. Mol Neurobiol 51 (2015), 1263–1270.
27. [27] Dibbens, L.M., Harkin, L.A., Richards, M., Hodgson, B.L., Clarke, A.L., Petrou, S., et al. The role of neuronal GABA(A) receptor subunit mutations in idiopathic generalized epilepsies. Neurosci Lett 453 (2009), 162–165.
28. [28] Hernandez, C.C., Gurba, K.N., Hu, N., Macdonald, R.L., The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6beta22 and 6beta2 GABA(A) receptor channel gating and expression. J Physiol 589 (2011), 5857–5878.
29. [29] Veeramah, K.R., Johnstone, L., Karafet, T.M., Wolf, D., Sprissler, R., Salogiannis, J., et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia 54 (2013), 1270–1281.
30. [30] Yang, Y., Vasylyev, D.V., Dib-Hajj, F., Veeramah, K.R., Hammer, M.F., Dib-Hajj, S.D., et al. Multistate structural modeling and voltage-clamp analysis of epilepsy/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state. J Neurosci 33 (2013), 16586–16593.
31. [31] Marini, C., Scheffer, I.E., Nabbout, R., Suls, A., De Jonghe, P., Zara, F., et al. The genetics of Dravet syndrome. Epilepsia 52:Suppl. 2 (2011), 24–29.
32. [32] Singh, N.A., Pappas, C., Dahle, E.J., Claes, L.R., Pruess, T.H., De Jonghe, P., et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet, 5, 2009, e1000649.
33. [33] Liao, W.P., Shi, Y.W., Long, Y.S., Zeng, Y., Li, T., Yu, M.J., et al. Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: associated with loss of function of Na(v) 1.1. Epilepsia 51 (2010), 1669–1678.